Developer docs
API playgroundTry for free, no card

Search company profiles

Curio Bioscience

Full company profile

uuid0007hjx

Namestring
Curio Bioscience
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Curio Bioscience is a Palo Alto-based, privately held life science tools company that developed spatial genomics and spatial transcriptomics kits for single-cell analysis. The company's core offerings consisted of two products: the Trekker Single-Cell Spatial Mapping Kit, a one-hour, instrument-free solution that enables researchers to pinpoint the exact locations of single cells upstream of single-nuclei NGS assays, and the Seeker Spatial Transcriptomics Kit, which captures whole transcriptomes of single cells with flexible array sizes and is designed to work across any species rather than being limited to human or mouse samples. Together, these products positioned Curio in the high-growth spatial omics segment of the next-generation sequencing market, targeting life science researchers and genomics laboratories working in cancer biology, developmental biology, immunology, and neuroscience.

The company's business model centered on selling consumable kits through parent company Takara Bio's global distribution network, which included direct sales representatives, an online storefront, and a certified service provider program. Marketing leveraged Takara Bio's content channels, including the BioView blog, technical webinars, and industry conferences. Pricing was not publicly disclosed. Curio was a small organization, with employee count reported in the 11-50 range, and was co-founded by Ari Chaney, who served as COO.

In February 2026, Curio Bioscience was acquired by Takara Bio, a strategic operating company in the biotechnology tools space. The acquisition was driven by Takara Bio's strategy to expand its spatial genomics capabilities and integrate Curio's Trekker and Seeker technologies into its broader NGS portfolio. Following the transaction, Curio ceased operating as an independent company and its products became part of Takara Bio's spatial omics product line.

Short descriptiontext

Curio Bioscience is a Palo Alto-based spatial genomics company that developed the Trekker Single-Cell Spatial Mapping Kit and Seeker Spatial Transcriptomics Kit for life science researchers, serving cancer, developmental, immunology, and neuroscience applications before being acquired by Takara Bio in February 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
spatial genomics, single-cell analysis, spatial transcriptomics, next-generation sequencing, gene expression mapping
Industry2 codes
PRIMARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAF
Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Spatial Genomics Reagents
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Curio Bioscience develops spatial omics kits that enable researchers to map the exact locations of single cells within tissue samples and capture whole-transcriptome gene expression with spatial context. Its two flagship products—the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit—are wet-lab kits used upstream of single-nuclei NGS assays to provide single-cell spatial genomics without requiring expensive dedicated instrumentation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Next-generation sequencing technology segment growing at projected CAGR of 21.2%
Product overview1 text field

Curio Bioscience was a spatial genomics company acquired by Takara Bio to expand its spatial genomics capabilities. The company's core offerings consisted of two spatial omics technologies: the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit. These technologies enabled researchers to examine single-cell location and behavior, providing spatial context to gene expression data. Following the acquisition by Takara Bio, these spatial omics products became part of Takara Bio's next-generation sequencing portfolio.

Product and service2 records
1Trekker Single-Cell Spatial Mapping Kit
CategorySpatial genomics kits
Description

A one-kit spatial mapping solution that allows researchers to pinpoint the exact locations of single cells within tissue samples upstream of single-nuclei NGS assays, delivering a complete spatial picture of single cells without requiring expensive dedicated instrumentation.

2Seeker Spatial Transcriptomics Kit
CategorySpatial transcriptomics kits
Description

A flexible spatial transcriptomics kit offered in two array sizes that captures the whole transcriptome of single cells with spatial context, using a universal workflow applicable to any species rather than being limited to human and mouse.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Takara Bio
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-13
Description

Takara Bio acquired Curio Bioscience to expand its spatial genomics capabilities. This acquisition positions Curio Bioscience's spatial omics technologies, including the Trekker and Seeker spatial mapping kits, as part of Takara Bio's comprehensive portfolio. The acquisition enables Takara Bio to strengthen its presence in the growing spatial genomics market.

novaoneadvisor.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct peer offering spatial omics solutions (CosMx SMI, GeoMx DSP) that compete head-to-head with Curio's single-cell spatial mapping kits for the same translational and academic research customers.

TypeDirect peer
Description

Direct competitor in single-cell and spatial transcriptomics, offering the Visium HD and Xenium platforms that overlap directly with Curio's Trekker and Seeker kits in target customers and applications.

TypeBroad incumbent
Description

Broad incumbent in NGS whose sequencers underpin the downstream read-out for Curio's kits; competing also via partnerships with spatial omics players, making it a strategic ecosystem peer.

TypeDirect peer
Description

Formerly Fluidigm, offers single-cell genomics instrumentation and assays that compete with Curio's instrument-free, kit-based single-cell spatial workflow for similar core facility customers.

5Takara Bio
TypeBroad incumbent
Description

Parent company and broad incumbent in life science tools, offering the larger SMART-Seq NGS portfolio into which Curio's spatial omics kits have now been integrated post-acquisition.

TypeDirect peer
Description

Emerging spatial omics player offering single-cell, subcellular resolution transcriptomics that overlaps with Curio's high-resolution spatial mapping positioning.

TypeBroad incumbent
Description

Broad life science tools incumbent with spatial biology (RNAscope) and proteomics reagents that compete broadly with Curio's spatial transcriptomics reagents for the same research end users.

TypeDirect peer
Description

Direct peer in spatial biology with PhenoCycler and PhenoImager platforms; competes for the same immuno-oncology and tumor microenvironment research dollars as Curio's spatial kits.

TypeDirect peer
Description

Direct competitor with the MERFISH-based spatial transcriptomics platform, serving the same single-cell spatial genomics use cases Curio addresses with Trekker and Seeker.

TypeEmerging player
Description

Single-cell sequencing company whose Evercode technology complements Curio's single-cell upstream workflows; partial overlap on single-cell NGS but without spatial context.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Curio Bioscience

Spatial Genomics Reagentscuriobioscience.com

Curio Bioscience is a Palo Alto-based spatial genomics company that developed the Trekker Single-Cell Spatial Mapping Kit and Seeker Spatial Transcriptomics Kit for life science researchers, serving cancer, developmental, immunology, and neuroscience applications before being acquired by Takara Bio in February 2026.

What Curio Bioscience does

Curio Bioscience is a Palo Alto-based, privately held life science tools company that developed spatial genomics and spatial transcriptomics kits for single-cell analysis. The company's core offerings consisted of two products: the Trekker Single-Cell Spatial Mapping Kit, a one-hour, instrument-free solution that enables researchers to pinpoint the exact locations of single cells upstream of single-nuclei NGS assays, and the Seeker Spatial Transcriptomics Kit, which captures whole transcriptomes of single cells with flexible array sizes and is designed to work across any species rather than being limited to human or mouse samples. Together, these products positioned Curio in the high-growth spatial omics segment of the next-generation sequencing market, targeting life science researchers and genomics laboratories working in cancer biology, developmental biology, immunology, and neuroscience.

The company's business model centered on selling consumable kits through parent company Takara Bio's global distribution network, which included direct sales representatives, an online storefront, and a certified service provider program. Marketing leveraged Takara Bio's content channels, including the BioView blog, technical webinars, and industry conferences. Pricing was not publicly disclosed. Curio was a small organization, with employee count reported in the 11-50 range, and was co-founded by Ari Chaney, who served as COO.

In February 2026, Curio Bioscience was acquired by Takara Bio, a strategic operating company in the biotechnology tools space. The acquisition was driven by Takara Bio's strategy to expand its spatial genomics capabilities and integrate Curio's Trekker and Seeker technologies into its broader NGS portfolio. Following the transaction, Curio ceased operating as an independent company and its products became part of Takara Bio's spatial omics product line.

Curio Bioscience firmographics

Firmographics
Name
Curio Bioscience
Website
https://curiobioscience.com
Company type
Private
Operating status
Acquired
Headcount range
1–10 employees
Short description
Curio Bioscience is a Palo Alto-based spatial genomics company that developed the Trekker Single-Cell Spatial Mapping Kit and Seeker Spatial Transcriptomics Kit for life science researchers, serving cancer, developmental, immunology, and neuroscience applications before being acquired by Takara Bio in February 2026.
Ownership category
akta.pro rank

Curio Bioscience industry classification

Industry
Product category
Spatial Genomics Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAF
Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Spatial genomics
  • Single-cell analysis
  • Spatial transcriptomics
  • Next-generation sequencing
  • Gene expression mapping

Where Curio Bioscience is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Markets served

Curio Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Distribution channels3 records

Marketing channels3 records

Curio Bioscience product offering

Product offering

Core offering

Curio Bioscience develops spatial omics kits that enable researchers to map the exact locations of single cells within tissue samples and capture whole-transcriptome gene expression with spatial context. Its two flagship products—the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit—are wet-lab kits used upstream of single-nuclei NGS assays to provide single-cell spatial genomics without requiring expensive dedicated instrumentation.

Product overview

Curio Bioscience was a spatial genomics company acquired by Takara Bio to expand its spatial genomics capabilities. The company's core offerings consisted of two spatial omics technologies: the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit. These technologies enabled researchers to examine single-cell location and behavior, providing spatial context to gene expression data. Following the acquisition by Takara Bio, these spatial omics products became part of Takara Bio's next-generation sequencing portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

  • Trekker Single-Cell Spatial Mapping Kit A one-kit spatial mapping solution that allows researchers to pinpoint the exact locations of single cells within tissue samples upstream of single-nuclei NGS assays, delivering a complete spatial picture of single cells without requiring expensive dedicated instrumentation.
  • Seeker Spatial Transcriptomics Kit A flexible spatial transcriptomics kit offered in two array sizes that captures the whole transcriptome of single cells with spatial context, using a universal workflow applicable to any species rather than being limited to human and mouse.

Quantifiable outcome

  • Next-generation sequencing technology segment growing at projected CAGR of 21.2%

Companies that use Curio Bioscience

Customer profile

Segments1 record

Ideal customer profiles2 records

Curio Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Curio Bioscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Takara BiocoreStrategic or Co-development Partner · 13 February 2026Takara Bio acquired Curio Bioscience to expand its spatial genomics capabilities. This acquisition positions Curio Bioscience's spatial omics technologies, including the Trekker and Seeker spatial mapping kits, as part of Takara Bio's comprehensive portfolio. The acquisition enables Takara Bio to strengthen its presence in the growing spatial genomics market.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Curio Bioscience competitors and assessment

Company assessment

Direct peers

  • NanoString Technologies (Bruker Spatial Biology): Direct peer offering spatial omics solutions (CosMx SMI, GeoMx DSP) that compete head-to-head with Curio's single-cell spatial mapping kits for the same translational and academic research customers.
  • 10x Genomics: Direct competitor in single-cell and spatial transcriptomics, offering the Visium HD and Xenium platforms that overlap directly with Curio's Trekker and Seeker kits in target customers and applications.
  • Standard BioTools: Formerly Fluidigm, offers single-cell genomics instrumentation and assays that compete with Curio's instrument-free, kit-based single-cell spatial workflow for similar core facility customers.
  • Resolve Biosciences: Emerging spatial omics player offering single-cell, subcellular resolution transcriptomics that overlaps with Curio's high-resolution spatial mapping positioning.
  • Akoya Biosciences: Direct peer in spatial biology with PhenoCycler and PhenoImager platforms; competes for the same immuno-oncology and tumor microenvironment research dollars as Curio's spatial kits.
  • Vizgen: Direct competitor with the MERFISH-based spatial transcriptomics platform, serving the same single-cell spatial genomics use cases Curio addresses with Trekker and Seeker.

Broad incumbents

  • Illumina: Broad incumbent in NGS whose sequencers underpin the downstream read-out for Curio's kits; competing also via partnerships with spatial omics players, making it a strategic ecosystem peer.
  • Takara Bio: Parent company and broad incumbent in life science tools, offering the larger SMART-Seq NGS portfolio into which Curio's spatial omics kits have now been integrated post-acquisition.
  • Bio-Techne: Broad life science tools incumbent with spatial biology (RNAscope) and proteomics reagents that compete broadly with Curio's spatial transcriptomics reagents for the same research end users.

Emerging players

  • Parse Biosciences: Single-cell sequencing company whose Evercode technology complements Curio's single-cell upstream workflows; partial overlap on single-cell NGS but without spatial context.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Curio Bioscience social profiles

Digital presence

Curio Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Curio Bioscience leadership team

Management profile

Number of profiles

Profiles1 record

Curio Bioscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Curio Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curio Bioscience

What does Curio Bioscience do?

Curio Bioscience develops spatial omics kits that enable researchers to map the exact locations of single cells within tissue samples and capture whole-transcriptome gene expression with spatial context. Its two flagship products—the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit—are wet-lab kits used upstream of single-nuclei NGS assays to provide single-cell spatial genomics without requiring expensive dedicated instrumentation.

Is Curio Bioscience a public or private company?

Curio Bioscience is a private company. It is classified as corporate owned and is currently acquired.

When was Curio Bioscience founded?

Curio Bioscience was founded in -1. It employs 1 to 10 people.

Where is Curio Bioscience based?

Curio Bioscience is headquartered in Palo Alto, United States, in the North America region.

Who are Curio Bioscience's main competitors?

Direct peers on record are NanoString Technologies (Bruker Spatial Biology), 10x Genomics, Standard BioTools, Resolve Biosciences, Akoya Biosciences and Vizgen. Broad incumbents are Illumina, Takara Bio and Bio-Techne. Parse Biosciences is listed as an emerging player.

Does Curio Bioscience have an API?

No public API is recorded for Curio Bioscience.

What industry is Curio Bioscience in?

Curio Bioscience's product category is Spatial Genomics Reagents. Its primary akta.pro industry code is HLAGANAC, Single-Cell & Spatial Omics Services, with a secondary code of HLAAAIAF, Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nova One AdvisorLife Science Tools Market Size To Exceed USD 512.93 Billion By 2035The global life science tools market is projected to grow from USD 198.47 billion in 2025 to USD 512.93 billion by 2035, representing a compound annual growth rate of 9.96% over the forecast period, driven by rising R&D expenditure, technological innovations, and increasing demand for advanced diagnostic tools. North America accounted for over 40% of market revenue in 2025, while Asia-Pacific is expected to grow at the fastest rate, with next-generation sequencing emerging as the fastest-growing technology segment at a projected CAGR of 21.2%. Recent industry developments include Yourgene Health launching the LightBench Discover precision genomic instrument, ONI introducing the Aplo Scope single-molecule super-resolution microscope, and Takara Bio acquiring Curio Bioscience to expand its spatial genomics capabilities.TakarabioTakara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutionsTakara Bio USA Holdings announced the acquisition of Curio Bioscience, adding spatial biology platforms to its single-cell omics portfolio. The deal combines Curio's Trekker and Seeker technologies with Takara Bio's NGS tools, enabling spatially resolved mapping of transcriptomes. The acquisition aims to provide deeper insights into tissue organization for research applications.YahooTakara Bio USA Holdings, Inc. Announces the Acquisition of Curio Bioscience, Adding Spatial Biology to Its Broad Portfolio of Single-Cell Omics SolutionsTakara Bio USA Holdings announced the acquisition of Curio Bioscience, a spatial genomics company. The deal combines Curio's Trekker and Seeker spatial technologies with Takara Bio's single-cell genomics portfolio. The acquisition aims to provide customers with spatially resolved maps of tissue organization.TakarabioTakara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutionsTakara Bio USA Holdings, Inc. announced the acquisition of Curio Bioscience to integrate spatial biology technologies into its single-cell omics portfolio. This strategic move combines Takara Bio’s NGS solutions with Curio’s Trekker and Seeker platforms to provide high-resolution insights into tissue spatial organization.Grand View ResearchSpatial Transcriptomics Market Size And Share Report, 2030The global spatial transcriptomics market is projected to grow from USD 337.5 million in 2023 to USD 902.2 million by 2030, driven by rising cancer prevalence and advancements in sequencing technologies. Key industry developments include Bruker's acquisition of NanoString Technologies and product launches by major players like 10x Genomics and Curio Bioscience to enhance diagnostic capabilities.Business Wire BlogCurio Bioscience Launches New Curio Seeker 10x10 Kit to Enable the Simultaneous Capture of Nearly One Million Spatial TranscriptomesCurio Bioscience announced the Curio Seeker 10x10 spatial mapping kit, enabling analysis of tissue up to one square centimeter. The kit delivers one hundred times more data than other whole transcriptome spatial analysis solutions and is compatible with all Illumina sequencers.Business Wire BlogCurio Bioscience Launches Industry’s First Unbiased, High-Resolution, Spatial Transcriptomics SolutionCurio Bioscience launched Curio Seeker, the world's first high-resolution, whole-transcriptome spatial mapping kit, on commercial operations. The kit uses the Slide-seq technique and offers 1-2 cell average resolution, compatible with all Illumina sequencers. It is the first in a suite of products for high-resolution discovery.